FDA Drug Approval, A203880, CYCLOSPORINE
FDA Drug Approval, A203880, CYCLOSPORINE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 203880
Company: TEVA PHARMS USA INC
Drug Name: CYCLOSPORINE
Active Ingredients: CYCLOSPORINE
Strength: 0.05%
Dosage Form/Route: EMULSION;OPHTHALMIC
Action Date: 12/14/2023
Marketing Status: Discontinued
Submission Classification: ORIG-1 TE Code: None
Company: TEVA PHARMS USA INC
Drug Name: CYCLOSPORINE
Active Ingredients: CYCLOSPORINE
Strength: 0.05%
Dosage Form/Route: EMULSION;OPHTHALMIC
Action Date: 12/14/2023
Marketing Status: Discontinued
Submission Classification: ORIG-1 TE Code: None
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details